Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Amantadine Versus Gabapentin to Attenuate the Hemodynamic Response to Laryngoscopy and Tracheal Intubation and Their Effect on β-endorphin

NCT03172234 is registered in ClinicalTrials.gov with Ghada Mohammed AboelFadl as lead sponsor.

NCT NCT03172234
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03172234 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Amantadine Versus Gabapentin to Attenuate the Hemodynamic Response to Laryngoscopy and Tracheal Intubation and Their Effect on β-endorphin
Lead sponsor
Ghada Mohammed AboelFadl
Phase
Phase 2/3
Overall status
Completed
Start date
June 15, 2017
Completion date
May 15, 2018
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

effect of laryngoscopy and tracheal intubation